Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 7,004 | 6,316 | 9,469 | 6,675 | 5,655 |
| Cost of Goods | 2,039 | 2,805 | 3,023 | 3,016 | 2,943 |
| Gross Profit | 4,965 | 3,511 | 6,446 | 3,659 | 2,712 |
| Operating Expenses | 12,446 | 15,287 | 14,353 | 14,926 | 18,142 |
| Operating Income | -7,442 | -10,971 | -7,884 | -11,251 | -14,487 |
| Interest Expense | 707 | 639 | 1,001 | 319 | 299 |
| Other Income | 390 | 494 | 759 | -738 | -39 |
| Pre-tax Income | -7,759 | -11,116 | -8,126 | -12,308 | -14,825 |
| Income Tax | 4 | 3 | 6 | 6 | 6 |
| Net Income Continuous | -7,763 | -11,119 | -8,132 | -12,314 | -14,831 |
| Net Income Discontinuous | -524 | N/A | N/A | N/A | N/A |
| Net Income | $-8,287 | $-11,119 | $-8,132 | $-12,314 | $-14,831 |
| EPS Basic Total Ops | -5.10 | -6.75 | -5.04 | -7.55 | -8.99 |
| EPS Basic Continuous Ops | -4.79 | -6.75 | -4.93 | -7.50 | -9.06 |
| EPS Basic Discontinuous Ops | -0.32 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -5.10 | -6.75 | -5.04 | -7.55 | -8.99 |
| EPS Diluted Continuous Ops | -4.79 | -6.75 | -4.93 | -7.50 | -9.06 |
| EPS Diluted Discontinuous Ops | -0.32 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -5.04 | -6.65 | -5.04 | N/A | N/A |
| EBITDA(a) | $-6,908 | $-9,735 | $-6,907 | $-10,336 | $-13,710 |